Carrick Therapeutics Competitors and Similar CompaniesClear all

CureVac's competitors and similar companies include Kyowa Kirin.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Kyowa Kirin
Kyowa Kirin
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
Founding Date
Founding Date
2000
Founding Date
2008
Type
Type
Public
Type
Public
Tags
Locations
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Locations
Tokyo, JP HQ
Sydney, AU
Shanghai, CN
Prague, CZ
Tampere, FI
Düsseldorf, DE
Hong Kong, HK
see more
Employees
Employees
82517% decrease
Employees
5,669
Valuation ($)
Valuation ($)
648.3 m
Valuation ($)
8.8 b

Financial

Revenue (est.)
Revenue (est.)
€535.2m (FY, 2024)
Revenue (est.)
¥496.8b (FY, 2025)
Cost of goods
Cost of goods
€9.7m (FY, 2024)
Cost of goods
¥114.3b (FY, 2025)
Gross profit
Gross profit
€534.4m (FY, 2024)
Gross profit
¥383.4b (FY, 2025)
Net income
Net income
€162.2m (FY, 2024)
Net income
¥67b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Kyowa Kirin
HQ
Tokyo, JP
Employees
5,669

Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.

View company